MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Oct 2021 Evaluate
The revenue zoomed 21.33% to Rs. 19.51 millions for the quarter ended September 2021 as compared to Rs. 16.08 millions during the corresponding quarter last year.The Profit  for the quarter ended September 2021 of  Rs. 1.00  millions  grew by 53.85% from Rs. 0.65 millions.OP of the company witnessed a marginal growth to 2.06 millions from 1.42 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 19.51 16.08 21.33 38.01 30.24 25.69 61.59 76.03 -18.99
Other Income 0.29 0.58 -50.00 0.70 0.90 -22.22 1.91 1.35 41.48
PBIDT 2.06 1.42 45.07 3.87 2.78 39.21 5.22 4.38 19.18
Interest 0.19 0.14 35.71 0.39 0.37 5.41 0.87 0.67 29.85
PBDT 1.87 1.28 46.09 3.48 2.41 44.40 4.35 3.71 17.25
Depreciation 0.50 0.46 8.70 1.00 0.92 8.70 1.91 1.95 -2.05
PBT 1.37 0.82 67.07 2.48 1.49 66.44 2.44 1.76 38.64
TAX 0.37 0.17 117.65 0.65 0.30 116.67 0.38 0.46 -17.39
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.40 -0.24 66.67
PAT 1.00 0.65 53.85 1.83 1.19 53.78 2.06 1.30 58.46
Equity 35.45 35.44 0.03 45.71 35.44 28.98 35.44 35.44 0.00
PBIDTM(%) 10.56 8.83 19.57 10.18 9.19 10.75 8.48 5.76 47.12
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..